9/30/2026
Political Picture

Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial

Filed by Deacon Rift
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial
Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
D
Deacon Rift
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via The Hill · The Hill

💬 Discussion

Sign in to join the discussion.
Be the first to comment on this story.
Loading…
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial — Political Picture